JP2020533415A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533415A5 JP2020533415A5 JP2020536720A JP2020536720A JP2020533415A5 JP 2020533415 A5 JP2020533415 A5 JP 2020533415A5 JP 2020536720 A JP2020536720 A JP 2020536720A JP 2020536720 A JP2020536720 A JP 2020536720A JP 2020533415 A5 JP2020533415 A5 JP 2020533415A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- antidepressants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762557412P | 2017-09-12 | 2017-09-12 | |
| US62/557,412 | 2017-09-12 | ||
| PCT/US2018/050339 WO2019055369A1 (en) | 2017-09-12 | 2018-09-11 | USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533415A JP2020533415A (ja) | 2020-11-19 |
| JP2020533415A5 true JP2020533415A5 (https=) | 2021-10-21 |
Family
ID=65630168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536720A Pending JP2020533415A (ja) | 2017-09-12 | 2018-09-11 | ナルコレプシーの処置におけるガボキサドールの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190076409A1 (https=) |
| EP (1) | EP3661507A4 (https=) |
| JP (1) | JP2020533415A (https=) |
| KR (1) | KR20200053570A (https=) |
| CN (1) | CN111328282A (https=) |
| AU (1) | AU2018331326A1 (https=) |
| CA (1) | CA3075478A1 (https=) |
| IL (1) | IL272962A (https=) |
| MX (1) | MX2020002741A (https=) |
| WO (1) | WO2019055369A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111328282A (zh) * | 2017-09-12 | 2020-06-23 | 奥维德医疗公司 | 加波沙朵在治疗发作性睡病中的用途 |
| US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
| JP7709202B2 (ja) | 2019-06-28 | 2025-07-16 | ユニバーシティ オブ コペンハーゲン | 睡眠障害を伴うｃｎｓ障害の治療 |
| MX2022014599A (es) | 2020-05-20 | 2022-12-16 | Certego Therapeutics Inc | Gaboxadol deuterado en anillo y su uso para el tratamiento de trastornos psiquiatricos. |
| US20250375429A1 (en) | 2024-05-29 | 2025-12-11 | Smarter Not Harder, Inc. | Obligate pairing of orthosteric and non-orthosteric gaba ligands in pharmaceutical formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200528098A (en) * | 2003-12-18 | 2005-09-01 | Lundbeck & Co As H | Treatment of insomnia in human patients |
| WO2005063248A1 (en) * | 2003-12-22 | 2005-07-14 | Sepracor Inc. | Modafinil combination therapy for improving sleep quality |
| US9480695B2 (en) * | 2011-09-29 | 2016-11-01 | The University Of Tokyo | Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder |
| US9050302B2 (en) * | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| CA2905457A1 (en) * | 2013-03-13 | 2014-10-09 | Aerial Biopharma, Llc | Treatment of cataplexy |
| US9682069B2 (en) * | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
| KR20190013737A (ko) * | 2016-05-26 | 2019-02-11 | 오비드 테라퓨틱스 인크. | 피프라드롤을 이용한 행동 증후군들의 치료 방법들 |
| CN111328282A (zh) * | 2017-09-12 | 2020-06-23 | 奥维德医疗公司 | 加波沙朵在治疗发作性睡病中的用途 |
-
2018
- 2018-09-11 CN CN201880072667.9A patent/CN111328282A/zh active Pending
- 2018-09-11 EP EP18856943.8A patent/EP3661507A4/en not_active Withdrawn
- 2018-09-11 KR KR1020207010674A patent/KR20200053570A/ko not_active Withdrawn
- 2018-09-11 CA CA3075478A patent/CA3075478A1/en active Pending
- 2018-09-11 MX MX2020002741A patent/MX2020002741A/es unknown
- 2018-09-11 AU AU2018331326A patent/AU2018331326A1/en not_active Abandoned
- 2018-09-11 WO PCT/US2018/050339 patent/WO2019055369A1/en not_active Ceased
- 2018-09-11 US US16/127,375 patent/US20190076409A1/en not_active Abandoned
- 2018-09-11 JP JP2020536720A patent/JP2020533415A/ja active Pending
-
2020
- 2020-02-27 IL IL272962A patent/IL272962A/en unknown
- 2020-03-25 US US16/829,423 patent/US20200222372A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533415A5 (https=) | ||
| Stiskal et al. | Neonatal paroxetine withdrawal syndrome | |
| EP3970712A2 (en) | Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof | |
| RU2020125170A (ru) | Композиции и способы улучшения биодоступности 5-гидрокситриптофана | |
| AU2010211491B2 (en) | Medical use of 5-benzylaminosalicylic acid derivative or its salt | |
| JP2023143940A5 (https=) | ||
| JP4874397B2 (ja) | ムスカリン性受容体ｍ１拮抗剤を使用する精神状態の処置 | |
| JP2012036212A5 (https=) | ||
| TW200835477A (en) | Methods for treating depression | |
| TWI409061B (zh) | 莫達非尼於縮短抗抑鬱劑效果的開始時間的用途 | |
| JP2009542820A5 (https=) | ||
| JP2011516604A (ja) | 鬱病患者の自殺行動の予防治療のためのミルナシプラン塩酸塩の（１ｓ，２ｒ）鏡像異性体の使用 | |
| DK2533774T3 (en) | USE OF AGOMELATIN FOR THE PREPARATION OF MEDICINALS FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE CONDITION (OCD) | |
| JPWO2019148087A5 (https=) | ||
| RU2009101146A (ru) | Лечение ожирения антагонистами мускаринового рецептора м1 | |
| RU2019123563A (ru) | Новые комбинации антагонистов н3-рецепторов и ингибиторов обратного захвата норадреналина и их терапевтическое применение | |
| MX2009001219A (es) | Composicion farmaceutica que contiene en combinacion saredutant y un inhibidor selectivo de recaptacion de serotonina o un inhibidor de recaptacion de serotonina/norepinefrina. | |
| RS51659B (sr) | Upotreba agomelatina za dobijanje lekova namenjenih tretmanu bipolarnih poremećaja | |
| RS50631B (sr) | Nova sprega agomelatina i inhibitora preuzimanja noradrenalina i farmaceutske smeše koje ih sadrže | |
| KR20140069120A (ko) | S1p 수용체 조절제를 포함하는 조합물 | |
| JP2009508829A (ja) | β３受容体作動薬およびモノアミン再取り込み阻害薬の会合、これらを含む薬剤組成物およびこの治療的使用 | |
| RU2022125828A (ru) | 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазин для предупреждения или лечения эмоциональной притупленности | |
| CN118401239A (zh) | 用于治疗抑郁症，包括难治性抑郁症的2-氟脱氯氯胺酮 | |
| JPWO2023150093A5 (https=) | ||
| JPWO2023281406A5 (https=) |